急性阑尾炎中遗漏阑尾肿瘤的肿瘤学风险
该单中心回顾性队列研究纳入2013至2021年2293例因急性阑尾炎行阑尾切除术的成人患者,发现1.6%有恶性或癌前病变,0.3%有良性非异型增生病变;类癌(NET)占多数且均为G1、小于2cm。侵袭性肿瘤在年龄较大、症状持续时间较长、阑尾直径较大及影像学怀疑复杂性阑尾炎的患者中更常见;严格筛选标准可排除侵袭性肿瘤患者。
要点
- 阑尾切除标本中偶发肿瘤以小型G1 NET为主,侵袭性恶性肿瘤罕见。
- 侵袭性肿瘤与年龄较大、阑尾直径较大及影像学复杂阑尾炎相关。
- 严格术前筛选标准可排除侵袭性肿瘤,支持筛选后抗生素治疗的安全性。
核心结论
- 偶发阑尾肿瘤多为小型低级别NET,侵袭性恶性肿瘤罕见且存在可识别的高危特征。
- 严格筛选的抗生素治疗在肿瘤学上是安全的。
研究设计与样本
- 中位年龄32岁(IQR 25-43),女性999例(44%)。
主要发现
- 2293例阑尾切除术中,37例(1.6%)有恶性或癌前病变,8例(0.3%)有良性非异型增生病变。
- NET 22例,均为G1且小于2cm,其中19例(86%)≤1cm,随访34个月无复发。
- 其他病变包括低级别阑尾黏液性肿瘤5例、转移性肿瘤3例、杯状细胞癌2例、黏液腺癌1例、低级别异型增生性息肉4例。
关键数值与推荐
- 抗生素治疗筛选标准:腹痛持续时间<14天;年龄<60岁;影像学无复杂性阑尾炎、阑尾直径<15mm、无可疑阑尾、腹膜、肝脏或骨骼病变。
- 所有侵袭性肿瘤患者均未完全满足上述标准;但17/22(77%)小型G1 NET和1/4(25%)低级别异型增生性息肉满足。
- 74%的队列满足潜在抗生素治疗筛选标准;在无并发症阑尾炎亚组中,85%符合。
临床怎么用
- 对拟行抗生素治疗的急性阑尾炎患者,应评估年龄、症状持续时间、阑尾直径及影像学有无复杂性病变。
- 严格应用筛选标准有助于排除侵袭性肿瘤患者,支持抗生素治疗的安全性。
- 阑尾切除标本应常规行组织病理学检查以发现偶发肿瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Antibiotic-only management (AOM) for uncomplicated acute appendicitis is increasingly adopted, raising concern about missed appendiceal neoplasms. OBJECTIVE: To assess the prevalence, histologic spectrum, and predictors of incidental appendiceal tumors after appendectomy for acute appendicitis. DESIGN, SETTING, AND PARTICIPANTS: This single-center retrospective cohort study was conducted from January 1, 2013, to December 31, 2021, at the tertiary surgical emergency center at Saint-Antoine Hospital in Paris, France. All consecutive adult patients undergoing appendectomy for acute appendicitis were eligible for inclusion. Data were analyzed in June 2025. EXPOSURE: Standard surgical management with appendectomy (no AOM); preoperative clinical variables, laboratory values, and imaging findings were assessed as potential predictors of appendiceal tumors. MAIN OUTCOME AND MEASURES: Prevalence and histopathological classification of incidental appendiceal neoplasms identified after appendectomy for acute appendicitis and preoperative clinical and radiologic factors associated with aggressive tumors. RESULTS: Among the cohort, median (IQR) age was 32 years (25-43), and 999 patients (44%) were female. Among 2293 appendectomies, 37 (1.6%) had malignant or premalignant lesions and 8 (0.3%) had benign nondysplastic lesions. Neuroendocrine tumors (NETs) (n = 22) predominated; all were grade 1 (G1) and smaller than 2 cm, with 19 (86%) measuring 1 cm or less without recurrence after 34 months of follow-up. Other lesions included low-grade appendiceal mucinous neoplasms (n = 5), metastatic tumors (n = 3), goblet cell carcinomas (n = 2), mucinous adenocarcinoma (n = 1), and low-grade dysplastic polyps (n = 4). Compared with nonneoplastic appendicitis, aggressive tumors (putting aside G1 NETs <2 cm and low-grade dysplasia) occurred more often in older patients (median [IQR] age, no malignant lesions: 32 years [25.0-43.0] vs malignant lesions: 45.0 years [37.8-57.2]; P = .03), with longer median symptom duration (no malignant lesions: 2 days vs malignant lesions: 1 day; P < .001), larger median (IQR) appendiceal diameter (no malignant lesions: 11.0 mm [9.0-13.0] vs malignant lesions: 18.0 mm [14.0-25.5]; P < .001), and radiologic suspicion of complicated appendicitis (no malignant lesions: 287 of 2234 [13%] vs malignant lesions: 6 of 11 [55%]; P = .001). In dedicated univariate analysis, NETs could not be distinguished from nonneoplastic appendicitis by any clinical or radiological variables tested. Using eligibility criteria for AOM derived from the univariate analysis (abdominal pain duration <14 days; age <60 years; and on imaging: uncomplicated appendicitis, appendiceal diameter <15 mm, and absence of suspicious appendiceal, peritoneal, hepatic, or bone lesions), none of the patients with aggressive tumors met the entirety of these criteria. However, 17 of 22 small G1 NETs (77%) and 1 of 4 low-grade dysplastic polyps (25%) fulfilled these criteria. By grouping all these selection criteria, 74% of the cohort met eligibility criteria for potential AOM; within the subgroup with uncomplicated appendicitis, 85% would have been eligible. CONCLUSIONS AND RELEVANCE: In this single-center cohort study, incidental appendiceal tumors were mostly small and low-grade NETs; aggressive malignancies were exceptional and occurred in identifiable high-risk profiles. Applied assembled preoperative selection criteria reliably excluded patients with aggressive tumors, thereby supporting the oncologic safety of AOM in rigorously selected individuals.
引用
- Germes M, Collard MK, Laroche S, et al. Oncologic Risk of Missed Appendiceal Tumors in Acute Appendicitis. JAMA Surg. 2026. PMID: 41879758. doi:10.1001/jamasurg.2026.0510
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。